Alto Neuroscience, Inc.
ANRO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001999480
No open-market purchases or sales by Alto Neuroscience, Inc. insiders were filed in the last 90 days; 114 institutions reported holding it in 13F filings for Q2 2026, worth $777.6M in total; no superinvestor holds it.
Superinvestors holding ANRO, Q2 2026
No superinvestor reported holding ANRO in Q2 2026.